Casma Therapeutics rallies $58.5 mln Series A
Cambridge, Massachusetts-based Casma Therapeutics Inc, a biotechnology company, has raised $58.5 million in Series A funding. The investor was Third Rock Ventures.
3 May 2018•1 min read
Cambridge, Massachusetts-based Casma Therapeutics Inc, a biotechnology company, has raised $58.5 million in Series A funding. The investor was Third Rock Ventures.
